Both agents affect appetite signaling and metabolic pathways, raising concerns about additive effects and unpredictable outcomes
Studies reveal that taking it with food or too much water reduces how well your body absorbs it
Tirzepatide: GLP-1 and GIP receptor activation Glucose-dependent insulinotropic polypeptide was historically called gastric inhibitory polypeptide
Animal studies suggest GLP-1 medications may reduce brain inflammation, improve neuronal signaling, and protect nerve cells
However, some studies have reported they may cause side effects, such as dizziness and headache
Other side effects, though may get a lot of media attention, are doubtful based on the current evidence from thousands of patients in clinical trials